584 related articles for article (PubMed ID: 16178895)
1. Malignant melanoma with neuroendocrine differentiation: clinical, histological, immunohistochemical and ultrastructural features of three cases.
Eyden B; Pandit D; Banerjee SS
Histopathology; 2005 Oct; 47(4):402-9. PubMed ID: 16178895
[TBL] [Abstract][Full Text] [Related]
2. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.
Yu CH; Chen HH; Liu CM; Jeng YM; Wang JT; Wang YP; Liu BY; Sun A; Chiang CP
J Oral Pathol Med; 2005 Oct; 34(9):540-5. PubMed ID: 16138892
[TBL] [Abstract][Full Text] [Related]
3. Rhabdomyosarcomatous (myoblastic?) phenotype of metastatic malignant melanoma. A case report.
Pasz-Walczak G; Jesionek-Kupnicka D; Kubiak R; Biernat W; Sygut J; Kordek R
Pol J Pathol; 2002; 53(2):97-100. PubMed ID: 12140874
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical spectrum of malignant melanoma. The common presence of keratins.
Miettinen M; Franssila K
Lab Invest; 1989 Dec; 61(6):623-8. PubMed ID: 2481151
[TBL] [Abstract][Full Text] [Related]
5. Rhabdomyoblastic differentiation in malignant melanoma in adults: report of 2 cases.
Gharpuray-Pandit D; Coyne J; Eyden B; Banerjee SS
Int J Surg Pathol; 2007 Jan; 15(1):20-5. PubMed ID: 17172493
[TBL] [Abstract][Full Text] [Related]
6. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
Gleason BC; Nascimento AF
Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
[TBL] [Abstract][Full Text] [Related]
7. Pigmented pulmonary carcinoid tumor. An immunohistochemical and ultrastructural study.
Gal AA; Koss MN; Hochholzer L; DeRose PB; Cohen C
Arch Pathol Lab Med; 1993 Aug; 117(8):832-6. PubMed ID: 7688214
[TBL] [Abstract][Full Text] [Related]
8. MSG-1 expression in benign and malignant melanocytic lesions of cutaneous and mucosal epithelium.
Sedghizadeh PP; Williams JD; Allen CM; Prasad ML
Med Sci Monit; 2005 Jul; 11(7):BR189-94. PubMed ID: 15990678
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical characteristics of melanoma.
Ohsie SJ; Sarantopoulos GP; Cochran AJ; Binder SW
J Cutan Pathol; 2008 May; 35(5):433-44. PubMed ID: 18399807
[TBL] [Abstract][Full Text] [Related]
10. Primary small cell malignant melanoma of the rectum: case report of a very rare tumor.
Wang G; Eyden B; Yao LF; Chen SZ; Banerjee SS
Ultrastruct Pathol; 2007; 31(4):315-20. PubMed ID: 17786832
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemical markers for cytoplasmic antigens in acquired melanosis, malignant melanomas, and nevi of the conjunctiva].
Hitzer S; Bialasiewicz AA; Richard G
Klin Monbl Augenheilkd; 1998 Oct; 213(4):230-7. PubMed ID: 9848068
[TBL] [Abstract][Full Text] [Related]
12. DMBT1 expression distinguishes anorectal from cutaneous melanoma.
Helmke BM; Renner M; Poustka A; Schirmacher P; Mollenhauer J; Kern MA
Histopathology; 2009 Jan; 54(2):233-40. PubMed ID: 19207948
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the hair follicle stem cell marker nestin in patients with malignant melanoma.
Tanabe K; Amoh Y; Kanoh M; Takasu H; Sakai N; Sato Y; Katsuoka K
Eur J Dermatol; 2010; 20(3):283-8. PubMed ID: 20156773
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of N-cadherin distinguishes a subset of metastasizing desmoplastic melanomas.
Attis MG; Burchette JL; Selim MA; Pham T; Soler AP
Hum Pathol; 2006 Jul; 37(7):899-905. PubMed ID: 16784991
[TBL] [Abstract][Full Text] [Related]
15. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological, immunohistochemical, and ultrastructural study of 13 cases of melanotic schwannoma.
Zhang HY; Yang GH; Chen HJ; Wei B; Ke Q; Guo H; Ye L; Bu H; Yang K; Zhang YH
Chin Med J (Engl); 2005 Sep; 118(17):1451-61. PubMed ID: 16157048
[TBL] [Abstract][Full Text] [Related]
17. Metastatic small cell malignant melanoma: a case requiring immunoelectronmicroscopy for the demonstration of lattice-deficient melanosomes.
Eyden B; Moss J; Shore I; Banerjee SS
Ultrastruct Pathol; 2005; 29(1):71-8. PubMed ID: 15931781
[TBL] [Abstract][Full Text] [Related]
18. PNL2 melanocytic marker in immunohistochemical evaluation of primary mucosal melanoma of the head and neck.
Morris LG; Wen YH; Nonaka D; DeLacure MD; Kutler DI; Huan Y; Wang BY
Head Neck; 2008 Jun; 30(6):771-5. PubMed ID: 18228523
[TBL] [Abstract][Full Text] [Related]
19. Desmoplastic malignant melanoma. A clinicopathologic study of 14 cases.
Walsh NM; Roberts JT; Orr W; Simon GT
Arch Pathol Lab Med; 1988 Sep; 112(9):922-7. PubMed ID: 3415443
[TBL] [Abstract][Full Text] [Related]
20. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
Fröhlich E; Mack AF; Garbe C; Klessen C
Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
